Search results

18 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
A New Test to Measure the Effectiveness of CF Drugs
A new lab model developed by UNC’s Carla Ribeiro, PhD, and colleagues can be used to test new therapeutics for cystic fibrosis.
Located in News / 2017 / November
Are e-cigarettes ‘safer’ than regular cigarettes?
UNC School of Medicine researchers lead new study showing that e-cigarettes trigger unique and potentially damaging immune responses in human airways.
Located in News / 2017 / October
Boucher Authors NEJM Review Article on ‘Muco-Obstructive Lung Disease’
The New England Journal of Medicine published an article by Richard Boucher, MD, that redefines four lung diseases into a broad grouping called ‘Muco-Obstructive Lung Diseases.’
Located in News / 2019 / May
Can Scientists Change Mucus to Make It Easier to Clear, Limiting Harm to Lungs?
UNC School of Medicine and Duke University researchers, led by Brian Button, PhD, show why coughing can’t force mucus free from airways to help people battle cystic fibrosis and chronic bronchitis, and how new treatments could alter mucus to make coughing more therapeutic.
Located in News / 2018 / November
CF Foundation honors UNC researchers for vital treatment
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
Located in News / 2014 / October
Cystic Fibrosis Discovery: Bacterial Burden Begins During First Years of Life
UNC School of Medicine scientists show that therapies to break up mucus in toddlers might offer the best route to a longer life for CF patients.
Located in News / 2018 / January
Discovery Shows How Mucus Build-up, Not Infections, Triggers Cystic Fibrosis Lung Damage
Giving mucus-thinning therapies in early childhood might delay the worst symptoms and infections associated with CF, according to a study led by Charles Esther, MD, PhD, and Marianne Muhlebach, MD. Their paper is the cover story of Science Translational Medicine.
Located in News / 2019 / April
Five genetic regions implicated in cystic fibrosis severity
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
Located in News / 2015 / September
Increased mucins pinned to worsening cystic fibrosis symptoms
The discovery from UNC School of Medicine researchers overturns a controversial research study and offers a path for creating and testing CF treatments.
Located in News / 2014 / June
New simple test could help cystic fibrosis patients find best treatment
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.
Located in News / 2017 / November